Clinical Operations is the process of running the clinical aspect of a Phase I-IV clinical trial. This is monitored and managed through the phases and regulatory authority approvals to ensure the effectiveness of the treatment and to eliminate any adverse events before being placed on the market for the general public. The process of clinical operations starts from First-In-Human (FIH) studies in Phase I that run through a Start up process of identifying a site and patients to participate in a trial, once this Phase is completed and the data collected the Phase will be closed out. This is repeated across the rest of Phase II-IV.
We are able to cover all aspects of the Clinical Operations team including but not limited to:
We have worked with a number of different companies from 20 person headcount to 30,000 person headcount so have the ability to manage large accounts and family ran CRO’s/Biotech/Pharma companies.
Clinical Development or Drug Development is a term that defines the process of developing a new drug from R&D to the market. Typically this vertical covers the transition from late preclinical/IND enabling studies, into first-in-human studies (FIH) and then throughout phase II and phase III.
Apsida have vast experience networking and sourcing experienced physicians and/or scientists with expertise in specific therapeutic areas and modalities (small molecules, biologics, peptides, vaccines, ATMPs). We are able to utilise all of our search offerings (Retained, Contingent, Contract/Interim) tailored to our clients’ needs to find talent at a variety of seniority levels
The Clinical Development team have had excellent success within this area, supporting clients who are in need of professionals in this area as clinical development is such an important element to get right. Our main success stories come from partnering start-up or mid-sized biotechnology companies across the US, UK and Europe where we have made placements such as Chief Medical Officers, VP Clinical Development, Medical Directors, Clinical Research Physicians, and Medical Monitors. In addition to our work in biotech, we also support our CRO and larger pharmaceutical partners with making important hires within their Clinical Development department.
Regulatory Affairs is a profession developed to protect public health by controlling the safety and efficacy of all products in areas of the life science industry. Regulatory Affairs is in place from early development through to commercialisation to ensure products are safe and make a worthwhile contribution to public health. Regulatory Affairs is present in Pharmaceutical, Biotech and Medical Device organisations.
Apsida’s Regulatory Affairs recruitment team have expertise placing professionals at all seniorities level across Pharmaceutical, Biotech and Medical Device companies. The group have completed one off niche searches and large hiring projects scaling teams, operating across Europe, Switzerland and North America. Our searches always incorporate a review of both the technical and personality fit for organisations whilst ensuring a positive candidate experience. Example placements the team have recently made:
Regulatory:
The clinical trials industry consists of companies in all shapes and sizes, ranging from therapy specific singular phase providers, through to large full-service CRO’s. Each of these organisations play a crucial role in the ongoing development of getting life-saving drugs and treatments to the market. Due to the amount of CRO’s out there, competition is fierce and therefore companies need world-class business development & sales teams to ensure their services are being marketed correctly.
Apsida has extensive networks consistent of Business Development, Inside Sales and Contract & Proposals throughout both the European and North American regions. Since our inception in 2019, below are some examples of placements made:
Furthermore, we do not believe in a ‘one size fits all’ approach when it comes to identifying good salespeople. Having partnered with some of the largest CRO’s globally, through to small, niche providers, we are able to offer an elite level understanding of the industry and place the right type of individual into your team, whether it’s a ‘hunter’, ‘farmer’ or a combination of the two!
The eClinical industry is representative of a collection of organisations that supports both Sponsor’s and CRO’s conduct clinical trials, via their technology platforms. The typical systems used are as follows:
Apsida was founded off the back of the leadership teams in-depth and long-standing networks with the eClinical industry, with an unrivalled track record in placing professionals throughout Europe and North America. This led to Apsida creating eClinical specific teams with both vertical and geographic focus, resulting in now a major part of the organisation being dedicated entirely to this pocket of the industry.
Having supported over 50% of the industries vendors, our expertise and now placement history consists of both Operational and Commercial hires from Entry through to C-Suite appointments. Typical roles recruited for are as follows:
A contract development and manufacturing company (CDMO) is a company within the pharmaceutical industry that provides drug development and manufacturing services. Pharmaceutical companies partner with CDMOs as a way to outsource drug development and drug manufacturing.
Full-service CDMOs can take on every aspect of drug development and manufacturing, and they also work with clients looking to outsource certain components of their process. It all depends on what each client needs.
I support all appointments within a CDMO from commercial appointments to manufacturing, engineering and operations appointments across all seniorities including C suite.
We have made appointments with a number of well-established CDMO’s across small and large molecule business including advanced therapy manufacturers. Notable appointments include:
Access & Strategy is the intersection between the clinical and commercial worlds. In broad terms, this covers anything from early stage health economics and modelling all the way to late stage commercial and corporate strategy. It has a huge impact on how successful a drug will be both commercially, in terms of price and reimbursement, as well as passing through HTA submissions and regulatory bodies. Early modelling is also critical as this provide a huge amount of insight into the potential reach, viability and access to products
The market can be split into two sections; industry and service provider. Apsida sits well within both of these and has a proven track record in placing in both sectors. Within service providers, we partner with management consultants and CROs specialising in anything from HEOR, Market Access, Insights & Analytics, Communications, PRO/COA (including Psychometrics), Commercial Strategy (Brand strategy, competitive intelligence, launch excellence etc.), Corporate Strategy to name a few. These range anywhere from entry-level associate consultants and analysts, niche project managers, all the way to SVPs and C-Suite executives.
Within industry, we cover similar niche verticals specialising in small to mid-sized biopharma, medical device and digital therapeutics. Market access capabilities include both strategic headquarter positions as well as field-based executives with an expertise in understanding market needs, trends and skillsets of high performers.
Typical roles recruited for are as follows: